Z22.330

Clinical Causes: Presence of Group B Streptococcus bacteria naturally residing in the body Colonization of the bacteria in the gastrointestinal or genitourinary tract Spread of bacteria from close contact with colonized individuals Asymptomatic carriage in healthy individuals without active infection

Key Symptoms: Typically, carriers are asymptomatic and do not experience any signs or symptoms In some cases, carriers may develop urinary tract infections (UTIs) Rarely, the bacteria can cause invasive infections such as sepsis or pneumonia in vulnerable individuals Pregnant women carrying GBS may have no symptoms but pose a risk to their newborns

Diagnosis Path: The identification of GBS carriers usually involves microbiological testing. During pregnancy, healthcare providers may conduct rectal and vaginal swabs typically between 35 and 37 weeks of gestation. These samples are cultured in a laboratory to detect the presence of Group B Streptococcus bacteria. In non-pregnant individuals, GBS carriage may be identified through routine testing or if they have recurrent infections. Laboratory tests are crucial for accurate diagnosis, which guides subsequent management decisions to mitigate transmission risks.

Treatment Protocols: In most cases, being a GBS carrier does not require treatment for the colonization itself. However, if there is an active infection or if a pregnant woman tests positive, antibiotics may be administered to eliminate or reduce bacteria during labor. Typical antibiotics include penicillin or ampicillin, which are effective in preventing transmission to the newborn. Carriers who are asymptomatic generally do not need antibiotics unless part of a specific clinical scenario or risk factor. It is important to follow healthcare guidance for testing and management to ensure safety and prevent infection transmission.